FI884914A0 - Nya insulinderivat. - Google Patents

Nya insulinderivat.

Info

Publication number
FI884914A0
FI884914A0 FI884914A FI884914A FI884914A0 FI 884914 A0 FI884914 A0 FI 884914A0 FI 884914 A FI884914 A FI 884914A FI 884914 A FI884914 A FI 884914A FI 884914 A0 FI884914 A0 FI 884914A0
Authority
FI
Finland
Prior art keywords
insulinderivat
nya
nya insulinderivat
Prior art date
Application number
FI884914A
Other languages
English (en)
Finnish (fi)
Other versions
FI884914A (fi
Inventor
Liselotte Langkjaer
Kjeld Norris
Jan Markussen
Klavs Holger Joergensen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27221014&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI884914(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DK94887A external-priority patent/DK94887D0/da
Priority claimed from DK356987A external-priority patent/DK356987D0/da
Priority claimed from DK540087A external-priority patent/DK157901C/da
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of FI884914A publication Critical patent/FI884914A/fi
Publication of FI884914A0 publication Critical patent/FI884914A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI884914A 1987-02-25 1988-10-24 Nya insulinderivat. FI884914A0 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK94887A DK94887D0 (da) 1987-02-25 1987-02-25 Praeparat med fordelagtige egenskaber
DK356987A DK356987D0 (ja) 1987-07-10 1987-07-10
DK540087A DK157901C (da) 1986-10-20 1987-10-16 Insulinpraeparat til parenteral administration indeholdende magnesiumioner
PCT/DK1988/000033 WO1988006599A1 (en) 1987-02-25 1988-02-24 Novel insulin derivatives

Publications (2)

Publication Number Publication Date
FI884914A FI884914A (fi) 1988-10-24
FI884914A0 true FI884914A0 (fi) 1988-10-24

Family

ID=27221014

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884914A FI884914A0 (fi) 1987-02-25 1988-10-24 Nya insulinderivat.

Country Status (12)

Country Link
EP (1) EP0280534B1 (ja)
JP (1) JP2606915B2 (ja)
AU (1) AU612141B2 (ja)
CA (1) CA1339416C (ja)
DE (2) DE10075034I1 (ja)
ES (1) ES2053723T3 (ja)
FI (1) FI884914A0 (ja)
IE (1) IE62879B1 (ja)
NL (1) NL300029I1 (ja)
NZ (1) NZ223630A (ja)
PT (1) PT86819B (ja)
WO (1) WO1988006599A1 (ja)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK257988D0 (da) * 1988-05-11 1988-05-11 Novo Industri As Nye peptider
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
HUT56857A (en) * 1988-12-23 1991-10-28 Novo Nordisk As Human insulin analogues
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
ZA924448B (en) * 1991-06-21 1993-12-17 Lilly Co Eli Insulin Analogs
US6869930B1 (en) 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
WO1995016708A1 (en) * 1993-12-17 1995-06-22 Novo Nordisk A/S Proinsulin-like compounds
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
AUPP609198A0 (en) * 1998-09-22 1998-10-15 Curtin University Of Technology Use of non-peptidyl compounds for the treatment of insulin related ailments
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
CN100424179C (zh) 2001-11-19 2008-10-08 诺沃挪第克公司 制备胰岛素化合物的方法
GB0206792D0 (en) 2002-03-22 2002-05-01 Leuven K U Res & Dev Normoglycemia
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
PL1641616T3 (pl) 2003-06-27 2011-09-30 Novo Nordisk As Wysoce wilgocioszczelny pojemnik dla medycznych mieszanin ciekłych
ATE483580T1 (de) 2003-12-22 2010-10-15 Novo Nordisk As Durchsichtiger, flexibler, undurchlässiger kunststoffbehälter zur lagerung von pharmazeutischen flüssigkeiten
MXPA06008209A (es) 2004-01-21 2006-08-31 Novo Nordisk As Conjugacion de peptidos mediada por transglutaminasa.
US8263551B2 (en) 2004-11-22 2012-09-11 Novo Nordisk A/S Soluble, stable insulin-containing formulations with a protamine salt
WO2008049711A1 (en) 2006-10-27 2008-05-02 Novo Nordisk A/S Peptide extended insulins
EP2514412A1 (en) * 2007-04-30 2012-10-24 Novo Nordisk A/S Highly Concentrated Insulin Solutions and Compositions
DK2229407T3 (en) 2008-01-09 2017-02-27 Sanofi Aventis Deutschland NEW INSULIN DERIVATIVES WITH EXTREMELY DELAYED TIME / EFFECTS PROFILE
EP2229406B1 (de) 2008-01-09 2015-04-22 Sanofi-Aventis Deutschland GmbH Neue insulinderivate mit extrem verzögertem zeit- / wirkungsprofil
TWI451876B (zh) 2008-06-13 2014-09-11 Lilly Co Eli 聚乙二醇化之離脯胰島素化合物
WO2010016069A1 (en) 2008-08-07 2010-02-11 Biocon Limited A process for preparation of insulin compounds
MX349717B (es) 2008-10-17 2017-08-09 Sanofi Aventis Deutschland Combinación de una insulina y un agonista de glp-1.
FR2943538B1 (fr) 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
HUE037735T2 (hu) 2009-11-13 2018-09-28 Sanofi Aventis Deutschland DesPro36exendin-4(1-39)-Lys6-NH2-t és metionint tartalmazó gyógyszerkészítmény
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
EP2359843A1 (en) 2010-01-21 2011-08-24 Sanofi Pharmaceutical composition for treating a metabolic syndrome
AR080884A1 (es) 2010-04-14 2012-05-16 Sanofi Aventis Conjugados de insulina-sirna
SI2611458T1 (sl) 2010-08-30 2017-01-31 Sanofi-Aventis Deutschland Gmbh Uporaba AVE0010 za izdelavo zdravila za zdravljenje sladkorne bolezni tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
EP2548570A1 (en) 2011-07-19 2013-01-23 Sanofi Pharmaceutical composition for treating a metabolic syndrome
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
AU2013346624B2 (en) 2012-11-13 2018-08-09 Adocia Quick-acting insulin formulation including a substituted anionic compound
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
US9656017B2 (en) 2014-06-20 2017-05-23 Howard E. Greene Infusion delivery devices and methods
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
TW201630622A (zh) 2014-12-16 2016-09-01 美國禮來大藥廠 速效胰島素組合物
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
WO2018222787A1 (en) 2017-06-01 2018-12-06 Eli Lilly And Company Rapid-acting insulin compositions
EP3915571A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action
EP3915572A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364116A (en) * 1964-11-02 1968-01-16 Squibb & Sons Inc Method of use of desalanino insulin compositions
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product
DE2252157C3 (de) * 1972-10-25 1976-03-18 Hoechst Ag Zwischenprodukte zur herstellung von insulin, insulin-analogen und -derivaten und verfahren zur herstellung von insulin, insulin analogen und derivaten
NL7314766A (ja) * 1972-10-31 1974-05-02
DE2253327A1 (de) * 1972-10-31 1974-05-09 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
DK147437A (en) * 1980-02-11 1900-01-01 Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
AU550068B2 (en) * 1981-03-10 1986-02-27 Novo Nordisk A/S Zinc insulin stabilized with calcium or magnesium salts
ZW17482A1 (en) * 1981-08-27 1982-11-17 Lilly Co Eli Pharmaceutical formulations comprising human insulin and human c-peptide
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation

Also Published As

Publication number Publication date
IE62879B1 (en) 1995-03-08
FI884914A (fi) 1988-10-24
EP0280534A3 (en) 1990-01-31
NL300029I1 (nl) 2001-02-01
EP0280534B1 (en) 1993-04-21
CA1339416C (en) 1997-09-02
IE880499L (en) 1988-08-25
JP2606915B2 (ja) 1997-05-07
JPH01502434A (ja) 1989-08-24
WO1988006599A1 (en) 1988-09-07
PT86819A (pt) 1988-03-01
DE3880346T2 (de) 1993-07-29
DE10075034I1 (de) 2001-05-23
DE3880346D1 (de) 1993-05-27
PT86819B (pt) 1992-05-29
AU612141B2 (en) 1991-07-04
EP0280534A2 (en) 1988-08-31
NZ223630A (en) 1989-11-28
AU1397688A (en) 1988-09-26
ES2053723T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
FI884914A0 (fi) Nya insulinderivat.
FI880173A0 (fi) Nya peptidasinhibitorer.
FI881825A0 (fi) Framstaellning av nya heterobicykliska kinolonderivat.
FI881650A0 (fi) Foerfarande foer framstaellning av nya acylderivat.
FI880469A0 (fi) Nya polyaminderivat.
FI884305A0 (fi) Nya amidinotricyklderivat.
FI884363A0 (fi) Nya aluminium-magnesium -hydroxifoereningar.
FI884627A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara dideoxicytidinderivat.
FI881571A (fi) Nya ribofuransyraderivator.
FI893937A0 (fi) Nya antiarytmiska aemnen ii.
FI881639A (fi) Foerfarande foer framstaellning av nya substituerade anilidderivat.
FI884304A (fi) Nya amidinoderivat.
FI882640A0 (fi) Nya heterocykliska pesticida foereningar.
FI881641A0 (fi) Foerfarande foer framstaellning av nya acylderivat.
FI883146A0 (fi) Nya foereningar.
FI884106A (fi) Foerfarande foer framstaellning av nya antibakteriella 4-oxo-3-kinolinkarboxylsyror.
FI871320A (fi) Nya langmuir-blodgettmembranstrukturer.
FI885063A (fi) Nya 4-demetoxi-antracyklinderivat.
FI884901A0 (fi) Nya rifamycinderivat.
FI884535A0 (fi) Foerfarande foer framstaellning av nya kinolinium- och isokinoliniumderivat.
FI881921A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara kinolintioetrar.
FI871462A (fi) Nya mineralprodukter.
FI873336A0 (fi) Nya makromolekyler.
FI880144A (fi) Nya makromolekyler.
FI870573A0 (fi) Nya etyleniskt omaettade foereningar innehaollande fosfinyl.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: NOVO NORDISK A/S